Oct 12, 2022 08:30AM
Jul 8, 2022 08:35AM
May 24, 2022 04:04PM
May 23, 2022 08:31AM
May 23, 2022 08:30AM
May 23, 2022 08:30AM
May 23, 2022 08:30AM Innoviva to Acquire Entasis Therapeutics
Apr 27, 2022 05:11PM
Apr 27, 2022 07:30AM
Apr 27, 2022 07:30AM
Mar 4, 2022 06:15AM
Mar 3, 2022 12:21PM
Mar 3, 2022 07:37AM
Mar 3, 2022 07:30AM Entasis Therapeutics Announces Year End 2021 Financial Results and Provides Business Update
Mar 3, 2022 07:30AM
Feb 2, 2022 04:34PM
Feb 2, 2022 04:33PM
Feb 2, 2022 04:33PM
Oct 19, 2021 09:00AM
Oct 19, 2021 09:00AM
Oct 19, 2021 09:00AM Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial
Oct 18, 2021 04:06PM
Oct 18, 2021 04:05PM
Oct 18, 2021 04:05PM
Aug 10, 2021 08:00AM
Aug 10, 2021 08:00AM
Jul 28, 2021 04:05PM
Jul 27, 2021 08:00AM Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
Jul 27, 2021 08:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All